LEHI, Utah / Nov 14, 2023 / Business Wire / Owlet, Inc. (“Owlet”) (NYSE: OWLT) today announced that it will participate in the BTIG Digital Health Forum, taking place on Monday, November 20, 2023, virtually. Kurt Workman, Owlet’s Co-Founder and Chief Executive Officer, and Kate Scolnick, Chief Financial Officer, are scheduled to engage in a fireside chat on Monday, November 20, at 11 a.m. Eastern Time. Management will also participate in 1x1 meetings which may be requested through BTIG.
About Owlet, Inc.
Owlet was founded by a team of parents in 2012. Owlet’s mission is to empower parents with the right information at the right time, to give them more peace of mind and help them find more joy in the journey of parenting. Owlet’s digital parenting platform aims to give parents real-time data and insights to help parents feel calmer and more confident. Owlet believes that every parent deserves peace of mind and the opportunity to feel their well-rested best. Owlet also believes that every child deserves to live a long, happy, and healthy life, and is working to develop products to help further that belief. To learn more, visit www.owletcare.com.
Last Trade: | US$3.23 |
Daily Change: | -0.01 -0.31 |
Daily Volume: | 2,688 |
Market Cap: | US$51.810M |
March 04, 2025 January 28, 2025 September 13, 2024 September 11, 2024 September 03, 2024 |
Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....
CLICK TO LEARN MOREImmix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MOREEnd of content
No more pages to load